Neurodegeneration News and Research

RSS

Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons.

Altered protein and mutated clusters of genes in Alzheimer’s disease

Alzheimer's disease (AD) diagnosis and treatment has been a challenge and this is mainly due to the varying degrees of degeneration and cognitive damage seen in different patients. The researchers from the University of California San Diego School of Medicine for the first time used the transcriptome to assess the proteins made from the genes in patients with AD, that could help in diagnosis.

23 Jul 2019

Aging nerve cells fail to take out the intracellular "trash"

Researchers at the Perelman School of Medicine at the University of Pennsylvania, have found that with age the neurons or nerve cells fail to perform an activity that they could when they were younger. The team explains that normal cells take out protein and other “trash” or “garbage” through a process of autophagy. This rids the cell of the dysfunctional proteins and aggregates of unused proteins.

22 Jul 2019

Common medications can masquerade as dementia in seniors

By all accounts the woman, in her late 60s, appeared to have severe dementia. She was largely incoherent. Her short-term memory was terrible. She couldn't focus on questions that medical professionals asked her.

18 Jul 2019

Researchers explain how 'viral' agents of neurological diseases ended up in our DNA

What if the missing ‘environmental’ factor in some of our deadliest neurological diseases were really written in our genome?

11 Jul 2019

Scientists discover rare autoimmune disease triggered by testicular cancer

A new autoimmune disease has been discovered that is triggered by testicular cancer. The condition is rare, but cases are growing.

8 Jul 2019

Novel imaging molecule reveals brain changes linked to progressive MS

Secondary progressive multiple sclerosis is a relentless disease. Over time, patients experience worsening physical, mental and mood-related symptoms.

2 Jul 2019

Researchers determine atomic interactions that stabilize phase-changing proteins

Most of the well-studied proteins in our bodies are like metal; some can change shape easily, like aluminum foil, and others are rigid, like steel beams, but they typically have a solid, well-defined structure.

2 Jul 2019

Quanterix announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year 2019 Award Winner in New England

Quanterix, announce Chairman and CEO of Quanterix, and Founder of Powering Precision Health, has been recognized with the Entrepreneur Of The Year 2019 Award.

From Quanterix 28 Jun 2019

Endogenous retrovirus type W found to be a major contributor to nerve damage in MS

Early disease stages of MS are primarily characterized by immune cell infiltration of the CNS. This causes inflammation that damages the so-called myelin sheaths.

28 Jun 2019

Scientists discover pathway that prevents buildup of Alzheimer's protein

St. Jude Children's Research Hospital scientists have discovered a pathway that functions like a car wash to prevent the buildup of a toxic protein associated with Alzheimer's disease. The report appeared online today in the journal Cell.

28 Jun 2019

Quanterix announces agreement to acquire UmanDiagnostics, world’s leading neurofilament light (Nf-l) antibody supplier

Quanterix announce agreement to acquire privately held UmanDiagnostics AB for $22.5 million.

From Quanterix 26 Jun 2019

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement.

From PhoreMost 25 Jun 2019

Complement system shown to remove dead cells in retinitis pigmentosa, contradicting previous research

Researchers have found that the complement system seems to protect against retinal degeneration in retinitis pigmentosa.

18 Jun 2019

Antioxidant protecting the brain linked to deterioration in areas susceptible to Alzheimer's

New research may explain why an antioxidant that protects the brain is also associated with deterioration in areas susceptible to Alzheimer's disease.

18 Jun 2019

Canadian Institutes of Health Research and partners fund CCNA's second phase

Thanks to a $46-million investment from the Canadian Institutes of Health Research (CIHR) and other funding partners, the Canadian Consortium on Neurodegeneration in Aging (CCNA) will be renewed for a second phase, announced today.

17 Jun 2019

Study suggests therapeutic solutions for pantothenate kinase-associated neurodegeneration

The scientific research team from the Universidad Pablo de Olavide led by doctor José Antonio Sánchez Alcázar has published a new study in the international magazines Molecular Neorubiology and Neural Regeneration Research.

11 Jun 2019

CAPON protein may facilitate link between two most well-known Alzheimer's culprits

A new protein involved in Alzheimer's disease has been identified by researchers at the RIKEN Center for Brain Science.

7 Jun 2019

Alzheimer's Drug Discovery Foundation announces first round of awards of Diagnostics Accelerator initiative

The Alzheimer's Drug Discovery Foundation announced today the first group of researchers who will receive funding through its Diagnostics Accelerator, a new research program that aims to fast-track the development of diagnostic tools and biomarkers for Alzheimer's disease and related dementias.

31 May 2019

Concussion symptoms can be reversed by magnetic stimulation

Concussion symptoms--such as loss of balance, hazy comprehension, sleep disturbance and ability to walk straight--can be reversed by a new type of magnetic stimulation, research at the University of Saskatchewan shows.

30 May 2019

Long-term antibiotic treatment slows growth of amyloid plaques in male mice but not in females

Researchers at The University of Chicago have demonstrated that the type of bacteria living in the gut can influence the development of Alzheimer's disease symptoms in mice.

17 May 2019